ImmunityBio, Inc. IBRX
Regular-session close
After hours · Nov 19, 7:58 PM ET
- YTD
- +231.82%
- 1 year
- +207.01%
IBRX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-309,188,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -309,188,000 | 88,936,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -398,124,000 | -783,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -397,341,000 | 18,330,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -415,671,000 | -128,187,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -287,484,000 | -114,091,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -173,393,000 | -17,197,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -156,196,000 | -80,125,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -76,071,000 | 7,524,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -83,595,000 | -38,442,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -45,153,000 | -17,607,000 | Not meaningful |
| FY 2015 | 2015-12-31 | -27,546,000 | -21,893,000 | Not meaningful |
| FY 2014 | 2014-12-31 | -5,653,000 | -4,982,000 | Not meaningful |
| FY 2013 | 2013-12-31 | -671,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:12.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
